Senores Pharmaceuticals Limited (NSE:SENORES)

India · Delayed Price · Currency is INR

1,224.10

-29.50 (-2.35%)

Oct 21, 2026, 3:29 PM IST

Senores Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 20, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	56,374	34,982	26,278	-	-	-
Market Cap Growth	67.75%	33.12%	-	-	-	-
Enterprise Value	58,508	35,572	28,923	-	-	-
Last Close Price	1224.10	759.60	570.60	-	-	-

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 20, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	43.26	30.32	44.87	-	-	-
Forward PE	31.55	25.94	-	-	-	-
PS Ratio	8.29	5.53	6.60	-	-	-
PB Ratio	5.84	3.63	3.24	-	-	-
P/TBV Ratio	10.28	6.38	4.65	-	-	-
P/OCF Ratio	90.85	56.38	-	-	-	-
PEG Ratio	0.83	0.57	-	-	-	-

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 20, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
EV/Sales Ratio	8.60	5.62	7.26	-	-	-
EV/EBITDA Ratio	30.26	21.89	33.94	-	-	-
EV/EBIT Ratio	37.00	25.95	39.69	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 20, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Debt / Equity Ratio	0.36	0.36	0.39	1.11	1.38	0.40
Debt / EBITDA Ratio	1.77	2.10	3.63	6.28	5.56	10.62
Net Debt / Equity Ratio	0.19	0.19	-0.09	1.06	1.37	0.32
Net Debt / EBITDA Ratio	0.94	1.15	-0.83	6.05	5.71	9.15
Net Debt / FCF Ratio	-	-0.92	0.35	-3.16	-1.29	-0.55
Asset Turnover	-	0.45	0.43	0.57	0.37	-
Inventory Turnover	-	3.57	3.99	5.38	4.19	-
Quick Ratio	-	1.55	2.60	0.77	0.74	2.31
Current Ratio	-	1.92	3.00	1.01	0.99	2.74
Return on Equity (ROE)	-	13.68%	11.18%	23.59%	20.55%	-
Return on Assets (ROA)	-	6.05%	4.93%	5.24%	7.16%	-
Return on Invested Capital (ROIC)	10.48%	11.07%	9.89%	10.81%	9.46%	2.25%
Return on Capital Employed (ROCE)	-	11.60%	7.40%	8.40%	13.80%	2.50%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 20, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Earnings Yield	2.31%	3.30%	2.23%	-	-	-
FCF Yield	-3.60%	-5.79%	-7.74%	-	-	-
Buyback Yield / Dilution	-15.01%	-26.64%	-41.13%	-103.16%	-131.33%	-